IL1B and pneumonia: Several iridoids were found to alleviate inflammatory response in A549 cells by reducing the release of proinflammatory cytokine IL-1β and IL-8, as well as increasing the expression of anti-inflammatory cytokine IL-10, which indicated that they may have therapeutic potential for pneumonia.